SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-17-004957
Filing Date
2017-03-22
Accepted
2017-03-22 08:35:16
Documents
7
Period of Report
2017-05-03
Effectiveness Date
2017-03-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A evok-def14a_20170503.htm DEF 14A 1078460
2 GRAPHIC g2017032210112476548129.jpg GRAPHIC 2530
3 GRAPHIC g2017032210112475348128.jpg GRAPHIC 4419
4 GRAPHIC g2017032210112479948130.jpg GRAPHIC 4489
5 GRAPHIC g2017032210113006448133.jpg GRAPHIC 37988
6 GRAPHIC g2017032210113004148132.jpg GRAPHIC 52015
7 GRAPHIC g2017032210112983848131.jpg GRAPHIC 2754
  Complete submission text file 0001564590-17-004957.txt   1224012
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36075 | Film No.: 17705734
SIC: 2834 Pharmaceutical Preparations